Neuroprotection in Preterm Infants

Table 1

Magnesium sulfate for neuroprotection.

	Magnesium ()	Control ()	RR, 95% CI
Cerebral palsy	104/3052	154/3093	0.68 (0.54–0.87),
Gross motor skill dysfunction	57/2967	94/3013	0.61 (0.44–0.85),
Infant mortality	443/3052	430/3093	1.04 (0.92–1.17)

Antenatal administration of magnesium sulfate significantly reduced the rate of cerebral palsy and gross motor skill dysfunction among preterm infants. The infant mortality rate remained unchanged [55].